Showing results (291-300 of 432) with videos related to
Sort By:
Pageof 44
Open Forum Infectious Diseases|May 18, 2016
Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient CharacteristicsJuan Berenguer, Antonio Rivero, Inmaculada Jarrín, et al.Journal of the International AIDS Society|November 15, 2014
Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART StudyAna Carrero-Gras, Antonio Antela, Jessica Muñoz-Rodríguez, et al.Nature Medicine|March 16, 2010
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsMaria J Buzón, Marta Massanella, Josep M Llibre, et al.Frontiers in Immunology|October 15, 2021
Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite ControllersAna-Irene Malo, Joaquim Peraire, Ezequiel Ruiz-Mateos, et al.The Journal of Antimicrobial Chemotherapy|April 12, 2022
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 studyMaria Saumoy, Jose Luís Sánchez-Quesada, Lambert Assoumou, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2016
Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV InfectionÁlvaro H Borges, Jacqueline Neuhaus, Abdel G Babiker, et al.Open Forum Infectious Diseases|November 29, 2023
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral ClassesJosé R Santos, Pere Domingo, Joaquín Portilla, et al.The American Journal of Tropical Medicine and Hygiene|December 28, 2020
Lack of Association of Initial Viral Load in SARS-CoV-2 Patients with In-Hospital MortalityAnna Carrasquer, Óscar M Peiró, Raul Sanchez-Gimenez, et al.Journal of Personalized Medicine|April 3, 2021
Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic SyndromeCarles Perpiñan, Laia Bertran, Ximena Terra, et al.Enfermedades Infecciosas Y Microbiologia Clinica|February 10, 2007
[Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients]Josep Maria Llibre-Codina, Miguel Angel Casado-Gómez, Rainel Sánchez-de la Rosa, et al.Pageof 44